Mulmit

Celularity IncCelularity Inc

CELU Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3126,550,000-61,308,000-91,716,000-3.59
2024-12-3154,220,000-38,358,000-57,892,000-2.64
2023-12-3122,771,000-192,287,000-196,295,000-11.02
2022-12-3117,975,000-25,600,00014,192,0000.95
2021-12-3121,335,000-109,059,000-100,118,000-1.49

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-19Philip & Daniele Barach Family Trust1,204,819
2026-06-19Philip & Daniele Barach Family Trust839,160
2026-06-19Barach Philip Alan1,204,819
2026-06-19Barach Philip Alan839,160
2026-06-19Barach Daniele Wolf1,204,819
2026-06-19Barach Daniele Wolf839,160
2026-04-13Brigido StephenPres., Functional Regeneration821
2026-04-13Brigido StephenPres., Functional Regeneration268
2026-04-13Brigido StephenPres., Functional Regeneration821
2026-04-13Haines John RSenior Exec Vice President1,641
2026-04-13Haines John RSenior Exec Vice President583
2026-04-13Haines John RSenior Exec Vice President1,641

8-K events

FiledItems
2026-09-14Other events
2026-08-07Officer or director change
2026-07-29Delisting or listing-standard notice
2026-06-30Entry into a material agreement · Creation of a direct financial obligation · Officer or director change · Financial statements and exhibits
2026-06-25Officer or director change
2026-06-12Delisting or listing-standard notice
2026-06-03Officer or director change · Regulation FD disclosure · Financial statements and exhibits
2026-05-28Entry into a material agreement · Creation of a direct financial obligation · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.